HomeMarketsSharesUSANA Health Sciences Inc

Trade USANA Health Sciences Inc - USNA CFD

Market is not available at the momentMarket information is presented
as of 2026-10-30T19:46:08+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.1
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.02237 %
(-$1.12)

Trade size with leverage ~ $5,000.00

Money from leverage ~ $$4,000.00


-0.02237%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
0.00015 %
($0.01)

Trade size with leverage ~ $5,000.00

Money from leverage ~ $$4,000.00


0.00015%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity1
Margin20.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close14.17
Open14.06
1-Year Change-27.82%
Day's Range14.06 - 14.35

Trade USANA Health Sciences Inc - USNA

About USANA Health Sciences, Inc.

USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal Care and Skincare and All Other. Its USANA Nutritionals Optimizers product line consists of supplements designed to meet individual health and nutritional needs. Its Essentials/CellSentials product line includes vitamin and mineral supplements that provides a total body nutrition for every age group beginning with children 13 months of age. Its Foods product line includes meal replacement shakes, snack bars, and other related products that provides macro-nutrition. Its Personal Care and Skincare product line includes its science-based personal care products and Celavive, its skincare system. Its All Other product line includes materials and online tools that are designed to assist its associates in building their businesses and in marketing its products.

Financial summary

BRIEF: For the fiscal year ended 01 January 2022, USANA Health Sciences, Inc. revenues increased 5% to $1.19B. Net income decreased 7% to $116.5M. Revenues reflect USANA® Nutritionals segment increase of 6% to $1.02B, USANA Foods segment increase of 5% to $83.1M, China segment increase of 6% to $563.5M, North Asia segment increase of 13% to $129.9M. Net income was offset by Associate incentives increase of 6% to $519.3M (expense), Selling/General/Admin.

Equity composition

Common Stock $.001 Par, 03/11, 50M auth., 15,843,837 o/s. Insiders control approx 53.74%. 1/93, spun-off from Gull Laboratories, Inc. 10/03, 8/98, 2-for-1 stock splits.

Latest shares articles

BAE Systems stock forecast
BAE Systems stock forecast: H1 results, guidance upgrade
BAE Systems is a UK defence and aerospace group listed in London. In August 2026, it secured a $149.8m US Navy award for work on the USS Boxer. Explore third-party BA. price targets and technical analysis. Past performance is not a reliable indicator of future results.
07:18, 16 October 2026
TAURON stock forecast
TAURON stock forecast: H1 earnings
TAURON is a Polish energy group. In the first half of 2026, revenue was broadly flat, while EBITDA and net profit fell amid higher CO2 allowance costs and coal consumption. Explore third-party analyst targets and technicals. Past performance is not a reliable indicator of future results.
12:04, 12 October 2026
Puma stock forecast
Puma stock forecast: Anta stake deal cleared
Puma is a German sportswear company. Chinese regulators have cleared Anta Sports’ proposed acquisition of an approximately 29% stake, with completion expected before the end of 2026. Explore third-party PUM price targets. Past performance is not a reliable indicator of future results.
10:19, 12 October 2026
Dino Polska stock forecast
Dino Polska stock forecast: H1 sales growth slows
Dino Polska is a Polish grocery retailer. In H1 2026, revenue rose 12.5% year on year to 18.0bn PLN, while like-for-like sales growth slowed to 2.2%. Explore third-party DNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
08:27, 12 October 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready